We are live on ! Find out more
5.23 USD
+0.46
9.64%
At close Updated Sep 16, 4:00 PM EDT
Pre-market
After hours
5.19
-0.04
0.76%
1 day
9.64%
5 days
8.96%
1 month
80.34%
3 months
82.87%
6 months
-2.97%
Year to date
51.16%
1 year
563.71%
5 years
-95.01%
10 years
-98.9%
 

About: MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. The company offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future and HC Securities, and MM Global. The Gujia segment provides market data services and consulting services to customers in China; and MM Global segment operates as an introducing broker that clears all transactions through a clearing broker dealer and earns commission income.

Employees: 31

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 50%
Negative 50%
Negative
Seeking Alpha
26 days ago
MMTec: Now We've Even Seen A 100% Revenue Drop
MMTec, Inc. reported a 100% drop in sales, with revenues falling from $807.5k to zero year-over-year. MTC's market cap exceeds $300 million despite having under $13 million in common equity and no revenue, raising major red flags. Massive dilution occurred, with shares outstanding rising from 25.19 million to 99.59 million, and further dilution is likely.
MMTec: Now We've Even Seen A 100% Revenue Drop
Neutral
Business Wire
2 months ago
Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform
BILLERICA, Mass.--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the "Breakthrough" special issue of Lab on a Chip. The study details a liver-centric multi-tissue chip (MTC) platform designed to capture the complex pharmacokinetic (PK) profiles of small-molecule drugs. The research marks a significant demonstration of how combinatorial NAMs en.
Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform
Neutral
PRNewsWire
9 months ago
MMTEC, Inc. Announces Receipt of Nasdaq Decision Regarding Minimum Bid Price Deficiency
HONG KONG , Dec. 11, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on December 9, 2025, the Company received a decision letter (the "Decision Letter") from the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC ("Nasdaq"). The Company previously received a determination letter (the "Determination Letter") which advised that for the 30 consecutive business days prior to the date of the Determination Letter the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").
MMTEC, Inc. Announces Receipt of Nasdaq Decision Regarding Minimum Bid Price Deficiency
Neutral
PRNewsWire
10 months ago
MMTEC, Inc. Announces Receipt of Nasdaq Delisting Determination Regarding Minimum Bid Price Deficiency
HONG KONG , Oct. 28, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on October 27, 2025, the Company received a determination letter (the "Determination Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") regarding a failure to meet Nasdaq's minimum bid price requirements. The Determination Letter advised that for the last 30 consecutive business the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").
MMTEC, Inc. Announces Receipt of Nasdaq Delisting Determination Regarding Minimum Bid Price Deficiency
Neutral
PRNewsWire
1 year ago
MMTEC, Inc. Announces 1-for-8 Reverse Stock Split
HONG KONG , Dec. 12, 2024 /PRNewswire/ -- MMTEC, Inc. ("MMTEC" or the "Company") (Nasdaq: MTC) reported that it expects to implement a 1-for-8 reverse stock split on its common stock. The effective date is scheduled to be December 18, 2024, subject to the Company's satisfaction of Nasdaq Operations notice requirements, with trading to begin on a split-adjusted basis at the market open on that day.
MMTEC, Inc. Announces 1-for-8 Reverse Stock Split
Neutral
PRNewsWire
2 years ago
MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG , July 10, 2024 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on July 8, 2024, the Company received a notification letter (the "Notification Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") regarding a failure to meet Nasdaq's minimum bid price requirements. The Notification Letter advised that for the last 30 consecutive business the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").
MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Neutral
PRNewsWire
2 years ago
MMTEC, INC. ANNOUNCES A PAUSE ON FINANCING ACTIVITIES IN THE NEXT SIX MONTHS
HONG KONG , May 8, 2024 /PRNewswire/ -- MMTEC, Inc. ("MMTEC" or the "Company") (Nasdaq: MTC), announced that it will suspend the acceptance of new investments and pause the Company's capital raising activities for the next six months. In light of the Company's current capital position, combined with a comprehensive assessment of the current market environment and our business operations, our management team has decided to suspend the Company's financing plans for the next six months.
MMTEC, INC. ANNOUNCES A PAUSE ON FINANCING ACTIVITIES IN THE NEXT SIX MONTHS
Price charts implemented using Lightweight Charts™